Abstract
Dapagliflozin (Farxiga) is a selective sodium-glucose cotransporter 2 inhibitor that promotes glycosuria. It is labeled for the treatment of type 2 di......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
